Best parameters for assessment
Bruce, B., Fries, J.F. 2003 The Stanford Health Assessment Questionnaire: a review of its
history, issues, progress, and documentation . J Rheumatol ., 30 :167-78.
Chopra, A. 2004 Rheumatology: Made in India. J. Indian Rheumatol. Assoc ., 12: 43-53.
David, M.L., Michael E.W. Rheumatoid arthritis. Lancet ., 358: 903–911.
Davis, M.J. et al. 1990 Comparison and evaluation of a disease activity index for use in
patients with rheumatoid arthritis. Br. J. Rheumatol ., 29 :111-115.
Detsky, A.S., Nagiie, I.G. 1990 A clinician’s guide to cost effectiveness analysis. Ann.
Med. , 113: 147-154.
Eisenberg, J.M. 1989 Clinical economics:A guide to economic analysis of clinical practices.
JAMA., 262 :2879-2886.
Ferraz, M.B., Quaresma, M.R., Aquino, L.R., Atra, E., Tugwell, P., Goldsmith, C.H .
1990 Reliability of pain scales in the assessment of literate and illiterate patients with
rheumatoid arthritis . J. Rheumatol., 17 :1022-4.
Felson, D.T., Anderson J.J., Boers, M., Bombardier, C. 1993 The American College of
Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis
clinical trials. Arthritis Rheum., 36 :729-740.
Felson, D.T., et al. 1995 American college of rheumatology; Preliminary definition of
improvement in rheumatoid arthritis. Arthritis Rheum., 38 :727-735.
Fries, J.F. et al . 1980 Measurement of patient outcome in arthritis. Arthritis Rheum ., 23 :
137-145.
Fries, J.F., Spitz, P.W., Youg, D.Y. 1982 The dimension of health outcome: the health
Assessment Questionnaire, disability and pain scales. J. Rheumatol ., 9 :789-793.
Gabriel, S., Tugwell, P., O’Brien, B., Yelin, E., Drummond, M., Ruff, B. 1999 Report of the
OMERACT task force on economic evaluation outcome Measures in Rheumatology. J.
Rheumatol ., 26 :203-206.
Gestel, A.M. et al . 1996 Development and validation of European League against
Rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum ., 39 :34-40.
Henk V. 2005 Early diagnosis of rheumatoid arthritis. Best Prac. Res. Clin. Rheumatol.,
19 :55–72.
Lipsky, P.E. et al. 2000 Infliximab and methotrexate in the treatment of rheumatoid arthritis.
N. Engl. J. Med ., 343 :1594-602.
Paulus, H.E., Egger, M.J., Ward, J.R., Williams, H.J. 1990 Analysis of improvement in
individual rheumatoid arthritis patients treated with disease modified anti rheumatoid
drugs, based on the findings in patients treated with placebo. Arthritis Rheum., 33 :477-
84.
Pincus, T., Summey, J.A., Soraci, S.A., Wallston, K.A., Hummon, N.P. 1983 Assessment
of patient satisfaction in activities of daily living using a modified Stanford Health
Assessment Questionnaire. Arthritis Rheum ., 26 :1346-53.
Prevoo, M.L., van’t Hof, M.A, Kuper, H.H., Van, L.M.A., Van de Putte, L.B. Van Riel,
P.L. 1995 Modified disease activity scores that include twenty-eight-joint counts:
Development and validation in a prospective longitudinal study of patients with
rheumatoid arthritis. Arthritis Rheum ., 38 :44-48.
Int. J. Bioinformatics and Biological Sci.: v.2 n.1&2, p. 85-94. March & June 2014
93